| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.2 | 7e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |